Atazanavir Sulfate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers, 25 USDMF, 7 CEP/COS, 16 EU WC, 2 KDMF, 17 NDC API, 22 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

67 Dossiers, 42 FDA Orange Book, 8 Europe, 11 Canada, 6 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 300MG BASE;150MG, CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 17 Kerry, 14 Roquette, 12 Microlex e.U, 11 Sigachi Industries, 9 Gangwal Healthcare, 8 BASF, 6 Gangwal Chemicals, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DFE Pharma, 4 Vasa Pharmachem, 4 Prachin Chemical, 4 ACG Worldwide, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Lonza Capsugel, 3 Nanjing Well Pharmaceutical, 3 Seppic, 2 Pharmatrans-Sanaq, 2 Ingredion Pharma Solutions, 1 Finar, 1 SPI Pharma, 1 DKSH, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales, 1 Qualicaps, 1 Rochem International Inc, 1 Pfanstiehl, 1 Actylis

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders, 24 Disintegrants & Superdisintegrants, 19 Direct Compression, 16 Lubricants & Glidants, 15 Thickeners and Stabilizers, 14 Granulation, 12 Coating Systems & Additives, 9 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 Taste Masking, 8 Empty Capsules, 6 Topical, 5 Controlled & Modified Release, 4 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 3 Parenteral, 3 Solubilizers, 2 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions

15 US Medicaid Prescriptions

MARKET PLACE

1 DOSSIERS // FDF

1 DOSSIERS // FDF

PATENTS

2 US Patents, 8 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 10 News

Information, Expiry & Status of FDA Orange Book Patents covering Atazanavir Sulfate

Atazanavir Sulfate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers

25 USDMF

7 CEP/COS

16 EU WC

2 KDMF

17 NDC API

22 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

67 Dossiers

42 FDA Orange Book

8 Europe

11 Canada

6 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 300MG BASE;150MG

CAPSULE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 200MG BASE

CAPSULE;ORAL - EQ 300MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

17 Kerry

14 Roquette

12 Microlex e.U

11 Sigachi Industries

9 Gangwal Healthcare

8 BASF

6 Gangwal Chemicals

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DFE Pharma

4 Vasa Pharmachem

4 Prachin Chemical

4 ACG Worldwide

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Lonza Capsugel

3 Nanjing Well Pharmaceutical

3 Seppic

2 Pharmatrans-Sanaq

2 Ingredion Pharma Solutions

1 Finar

1 SPI Pharma

1 DKSH

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

1 Qualicaps

1 Rochem International Inc

1 Pfanstiehl

1 Actylis

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders

24 Disintegrants & Superdisintegrants

19 Direct Compression

16 Lubricants & Glidants

15 Thickeners and Stabilizers

14 Granulation

12 Coating Systems & Additives

9 Co-Processed Excipients

8 Film Formers & Plasticizers

8 Taste Masking

8 Empty Capsules

6 Topical

5 Controlled & Modified Release

4 Emulsifying Agents

3 Chewable & Orodispersible Aids

3 Parenteral

3 Solubilizers

2 Surfactant & Foaming Agents

CAPSULE;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons